Long-Term Outcome of Mechanical Pulmonary Valve Replacement in 121 Patients with Congenital Heart Disease

Maziar Gholampour Dehaki; Alireza Alizadeh Ghavidel; Gholamreza Omrani; Hoda Javadikasgari

doi:10.1055/s-0034-1387129

The Thoracic and Cardiovascular Surgeon, Table of Contents

Thorac Cardiovasc Surg 2015; 63(05): 367-372
DOI: 10.1055/s-0034-1387129

Original Cardiovascular

Georg Thieme Verlag KG Stuttgart · New York

Long-Term Outcome of Mechanical Pulmonary Valve Replacement in 121 Patients with Congenital Heart Disease

Maziar Gholampour Dehaki

¹Department of Cardiovascular Surgery, Heart Valve Disease Research Center, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran

,

Alireza Alizadeh Ghavidel

¹Department of Cardiovascular Surgery, Heart Valve Disease Research Center, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran

,

Gholamreza Omrani

¹Department of Cardiovascular Surgery, Heart Valve Disease Research Center, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran

,

Hoda Javadikasgari

¹Department of Cardiovascular Surgery, Heart Valve Disease Research Center, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran

› Author Affiliations

Abstract

All articles of this category

Abstract

Background A tissue valve is the prosthesis of choice in the majority of children and adults requiring pulmonary valve replacement (PVR). Mechanical valves, on the other hand, are more durable but require anticoagulation therapy and carry the elevated risk of thrombosis. The aim of this study was to investigate the long-term outcomes of mechanical prosthetic valves in a single referral tertiary center.

Patients and Methods Recorded data of 121 patients who underwent mechanical PVR between April 2003 and April 2013 at our center were reviewed, retrospectively. Eighty-four patients (69.4%) were male and their mean age was 23.12 ± 7.86 years. Tetralogy of Fallot was the most common diagnosis (n = 109). Complete follow-up was performed for all patients (mean 7.02 ± 1.90 years).

Results Nobody died and no significant bleeding event was detected during follow-up. Mechanical valve malfunction happened in 10 patients (8.3%) while in 1 of them malfunction happened because of pannus formation and in the remaining 9 because of thrombosis. Just one of the thrombotic events could not be treated with streptokinase and required reoperation. Freedom from reoperation rates were 100, 99, and 98% at 1, 5, and 10 years, respectively; freedom from valve thrombosis event rates were 100, 93, and 91% at 1, 5, and 10 years, respectively; and freedom from bleeding event rates was 98% at 1, 5, and 10 years.

Conclusion Mechanical prosthetic valves demonstrated excellent durability and a low risk of valve thrombosis at the pulmonary position when patients are adequately anticoagulated.

Keywords

pulmonary valve replacement - mechanical valve - congenital heart disease

Full Text

References

References
1 Fiore AC, Rodefeld M, Turrentine M , et al. Pulmonary valve replacement: a comparison of three biological valves. Ann Thorac Surg 2008; 85 (5) 1712-1718 , discussion 1718
2 Lee C, Park CS, Lee CH , et al. Durability of bioprosthetic valves in the pulmonary position: long-term follow-up of 181 implants in patients with congenital heart disease. J Thorac Cardiovasc Surg 2011; 142 (2) 351-358
3 Ilbawi MN, Lockhart CG, Idriss FS , et al. Experience with St. Jude Medical valve prosthesis in children. A word of caution regarding right-sided placement. J Thorac Cardiovasc Surg 1987; 93 (1) 73-79
4 Kiyota Y, Shiroyama T, Akamatsu T, Yokota Y, Ban T. In vitro closing behavior of the St. Jude Medical heart valve in the pulmonary position. Valve incompetence originating in the prosthesis itself. J Thorac Cardiovasc Surg 1992; 104 (3) 779-785
5 Pass HI, Sade RM, Crawford FA, Hohn AR. Cardiac valve prostheses in children without anticoagulation. J Thorac Cardiovasc Surg 1984; 87 (6) 832-835
6 Rosti L, Murzi B, Colli AM , et al. Mechanical valves in the pulmonary position: a reappraisal. J Thorac Cardiovasc Surg 1998; 115 (5) 1074-1079
7 Haas F, Schreiber C, Hörer J, Kostolny M, Holper K, Lange R. Is there a role for mechanical valved conduits in the pulmonary position?. Ann Thorac Surg 2005; 79 (5) 1662-1667 , discussion 1667–1668
8 Waterbolk TW, Hoendermis ES, den Hamer IJ, Ebels T. Pulmonary valve replacement with a mechanical prosthesis. Promising results of 28 procedures in patients with congenital heart disease. Eur J Cardiothorac Surg 2006; 30 (1) 28-32
9 Simoons M, Topol E, Califf R , et al. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators. N Engl J Med 1993; 329 (10) 673-682
10 Pettersen MD, Du W, Skeens ME, Humes RA. Regression equations for calculation of z scores of cardiac structures in a large cohort of healthy infants, children, and adolescents: an echocardiographic study. J Am Soc Echocardiogr 2008; 21 (8) 922-934
11 Lindsey CW, Parks WJ, Kogon BE, Sallee III D, Mahle WT. Pulmonary valve replacement after tetralogy of Fallot repair in preadolescent patients. Ann Thorac Surg 2010; 89 (1) 147-151
12 Cheung EW-Y, Wong WH-S, Cheung Y-F. Meta-analysis of pulmonary valve replacement after operative repair of tetralogy of fallot. Am J Cardiol 2010; 106 (4) 552-557
13 Oosterhof T, Meijboom FJ, Vliegen HW , et al. Long-term follow-up of homograft function after pulmonary valve replacement in patients with tetralogy of Fallot. Eur Heart J 2006; 27 (12) 1478-1484
14 Yemets IM, Williams WG, Webb GD , et al. Pulmonary valve replacement late after repair of tetralogy of Fallot. Ann Thorac Surg 1997; 64 (2) 526-530
15 Forbess JM, Shah AS, St Louis JD, Jaggers JJ, Ungerleider RM. Cryopreserved homografts in the pulmonary position: determinants of durability. Ann Thorac Surg 2001; 71 (1) 54-59 , discussion 59–60
16 Akins CW, Miller DC, Turina MI , et al. Guidelines for reporting mortality and morbidity after cardiac valve interventions. Eur J Cardiothorac Surg 2008; 33 (4) 523-528
17 Brown ML, Dearani JA, Burkhart HM. The adult with congenital heart disease: medical and surgical considerations for management. Curr Opin Pediatr 2009; 21 (5) 561-564
18 Morishita K, Kawaharada N, Fukada J , et al. Three or more median sternotomies for patients with valve disease: role of computed tomography. Ann Thorac Surg 2003; 75 (5) 1476-1480 , discussion 1481
19 Shin HJ, Kim YH, Ko JK, Park IS, Seo DM. Outcomes of mechanical valves in the pulmonic position in patients with congenital heart disease over a 20-year period. Ann Thorac Surg 2013; 95 (4) 1367-1371
20 Dos L, Muñoz-Guijosa C, Mendez AB , et al. Long term outcome of mechanical valve prosthesis in the pulmonary position. Int J Cardiol 2011; 150 (2) 173-176
21 Stulak JM, Dearani JA, Burkhart HM , et al. The increasing use of mechanical pulmonary valve replacement over a 40-year period. Ann Thorac Surg 2010; 90 (6) 2009-2014 , discussion 2014–2015
22 Ilbawi MN, Idriss FS, DeLeon SY , et al. Valve replacement in children: guidelines for selection of prosthesis and timing of surgical intervention. Ann Thorac Surg 1987; 44 (4) 398-403
23 Burger W, Kneissl GD, Hartmann A , et al. Successful thrombolysis after prosthetic pulmonary valve obstruction under aspirin monotherapy. Ann Thorac Surg 1997; 64 (1) 255-257 , discussion 257–258
24 Nurozler F, Bradley SM. St. Jude medical valve in pulmonary position: anticoagulation and thrombosis. Asian Cardiovasc Thorac Ann 2002; 10 (2) 181-183
25 Chan WS, Anand S, Ginsberg JS. Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature. Arch Intern Med 2000; 160 (2) 191-196
26 Canfield RE, O'Connor JF, Wilcox AJ. Measuring human chorionic gonadotropin for detection of early pregnancy loss. Reprod Toxicol 1988; 2 (3-4) 199-203
27 Everett C. Incidence and outcome of bleeding before the 20th week of pregnancy: prospective study from general practice. BMJ 1997; 315 (7099) 32-34
28 Vitale N, De Feo M, De Santo LS, Pollice A, Tedesco N, Cotrufo M. Dose-dependent fetal complications of warfarin in pregnant women with mechanical heart valves. J Am Coll Cardiol 1999; 33 (6) 1637-1641
29 Bonhoeffer P, Boudjemline Y, Saliba Z , et al. Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction. Lancet 2000; 356 (9239) 1403-1405
30 McElhinney DB, Cheatham JP, Jones TK , et al. Stent fracture, valve dysfunction, and right ventricular outflow tract reintervention after transcatheter pulmonary valve implantation: patient-related and procedural risk factors in the US Melody Valve Trial. Circ Cardiovasc Interv 2011; 4 (6) 602-614
31 Eicken A, Ewert P, Hager A , et al. Percutaneous pulmonary valve implantation: two-centre experience with more than 100 patients. Eur Heart J 2011; 32 (10) 1260-1265
32 Biermann D, Schönebeck J, Rebel M, Weil J, Dodge-Khatami A. Left coronary artery occlusion after percutaneous pulmonary valve implantation. Ann Thorac Surg 2012; 94 (1) e7-e9
33 Vergales JE, Wanchek T, Novicoff W, Kron IL, Lim DS. Cost-analysis of percutaneous pulmonary valve implantation compared to surgical pulmonary valve replacement. Catheter Cardiovasc Interv 2013; 82 (7) 1147-1153